H.J. Meadows
Neuroscience Research
SmithKline Beecham Pharmaceuticals
New Frontiers Science Park
Third Avenue
UK
Name/email consistency: high
- The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. Meadows, H.J., Chapman, C.G., Duckworth, D.M., Kelsell, R.E., Murdock, P.R., Nasir, S., Rennie, G., Randall, A.D. Brain Res. (2001)
- Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel. Meadows, H.J., Randall, A.D. Neuropharmacology (2001)
- Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Meadows, H.J., Benham, C.D., Cairns, W., Gloger, I., Jennings, C., Medhurst, A.D., Murdock, P., Chapman, C.G. Pflugers Arch. (2000)
- Sensitivity to conotoxin block of splice variants of rat alpha 1B (rbBII) subunit of the N-type calcium channel coexpressed with different beta subunits in Xenopus oocytes. Meadows, H.J., Benham, C.D. Ann. N. Y. Acad. Sci. (1999)